GI & Endoscopy

Here are the five most read gastroenterology and endoscopy stories from Feb. 6 to Feb. 10, 2017.

Here are four gastroenterologists in the news this past week.

Frederick Gandolfo, MD, penned a column for Gastroenterology & Endoscopy on the possible use of frozen stool in treating Clostridium difficile.

Athens-based East Texas Medical Center expanded its gastroenterology lab, The Athens Review reports.

The second circuit court in New York reviewed claims that Japan-based Takeda Pharmaceuticals delayed a competitor from releasing a generic version of Actos, a diabetes drug, Court House News reports.

John Shekleton, MD, is a gastroenterologist at Frankfort-based Commonwealth Specialists of Kentucky.

Jupiter (Fla.) Medical Center partnered with New York City-based Mount Sinai Health to improve its digestive health clinical services and research efforts, The Courier Palm reports.

Bethesda, Md.-based GI Quality Improvement Consortium tapped Glenn Eisen, MD, to be its next president and chair of its board of directors.

After President Donald Trump signed an executive order banning immigration from seven countries, several gastroenterology facing professional societies expressed concerns about the upcoming Digestive Disease Week, Gastroenterology & Endoscopy reports.

Israel-based Motus GI raised $25.6 million in its latest fundraising round with 171 investors contributing to the round, Mass Device reports.